Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Urinary Bladder Neoplasms 5Recurrence 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms, Basal Cell 1Keratosis, Actinic 1Colorectal Neoplasms 1Carcinoma, Basal Cell 1

Interventions

Aminolevulinic Acid 18Fluorouracil 17Photochemotherapy 15Imiquimod 11Cryotherapy 93-ingenyl angelate 9methyl 5-aminolevulinate 8calcipotriene 5Radiotherapy 4Prilocaine 4Petrolatum 4Lidocaine 4tirbanibulin 3Niacinamide 3Tomography, Optical Coherence 2Therapeutics 2Solutions 2Phototherapy 2Gels 2Diclofenac 2Cryosurgery 2Celecoxib 2Blue Light 2Biopsy 21-phenyl-3,3-dimethyltriazene 2tazarotene 1perillyl alcohol 1dexpanthenol 1dehydroftorafur 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Keratosis, Actinic × 5-aminolevulinic acid hexyl ester × Clear all
NCT02149342 2016-07-11

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

Joint Authority for Päijät-Häme Social and Health Care

Phase 1/2 Completed
14 enrolled 8 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡